Cargando…

Mechanotransduction and Adrenergic Stimulation in Arrhythmogenic Cardiomyopathy: An Overview of in vitro and in vivo Models

Arrhythmogenic Cardiomyopathy (AC) is a rare inherited heart disease, manifesting with progressive myocardium degeneration and dysfunction, and life-threatening arrhythmic events that lead to sudden cardiac death. Despite genetic determinants, most of AC patients admitted to hospital are athletes or...

Descripción completa

Detalles Bibliográficos
Autores principales: Beffagna, Giorgia, Sommariva, Elena, Bellin, Milena
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7689294/
https://www.ncbi.nlm.nih.gov/pubmed/33281612
http://dx.doi.org/10.3389/fphys.2020.568535
_version_ 1783613835675959296
author Beffagna, Giorgia
Sommariva, Elena
Bellin, Milena
author_facet Beffagna, Giorgia
Sommariva, Elena
Bellin, Milena
author_sort Beffagna, Giorgia
collection PubMed
description Arrhythmogenic Cardiomyopathy (AC) is a rare inherited heart disease, manifesting with progressive myocardium degeneration and dysfunction, and life-threatening arrhythmic events that lead to sudden cardiac death. Despite genetic determinants, most of AC patients admitted to hospital are athletes or very physically active people, implying the existence of other disease-causing factors. It is recognized that AC phenotypes are enhanced and triggered by strenuous physical activity, while excessive mechanical stretch and load, and repetitive adrenergic stimulation are mechanisms influencing disease penetrance. Different approaches have been undertaken to recapitulate and study both mechanotransduction and adrenergic signaling in AC, including the use of in vitro cellular and tissue models, and the development of in vivo models (particularly rodents but more recently also zebrafish). However, it remains challenging to reproduce mechanical load stimuli and physical activity in laboratory experimental settings. Thus, more work to drive the innovation of advanced AC models is needed to recapitulate these subtle physiological influences. Here, we review the state-of-the-art in this field both in clinical and laboratory-based modeling scenarios. Specific attention will be focused on highlighting gaps in the knowledge and how they may be resolved by utilizing novel research methodology.
format Online
Article
Text
id pubmed-7689294
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-76892942020-12-04 Mechanotransduction and Adrenergic Stimulation in Arrhythmogenic Cardiomyopathy: An Overview of in vitro and in vivo Models Beffagna, Giorgia Sommariva, Elena Bellin, Milena Front Physiol Physiology Arrhythmogenic Cardiomyopathy (AC) is a rare inherited heart disease, manifesting with progressive myocardium degeneration and dysfunction, and life-threatening arrhythmic events that lead to sudden cardiac death. Despite genetic determinants, most of AC patients admitted to hospital are athletes or very physically active people, implying the existence of other disease-causing factors. It is recognized that AC phenotypes are enhanced and triggered by strenuous physical activity, while excessive mechanical stretch and load, and repetitive adrenergic stimulation are mechanisms influencing disease penetrance. Different approaches have been undertaken to recapitulate and study both mechanotransduction and adrenergic signaling in AC, including the use of in vitro cellular and tissue models, and the development of in vivo models (particularly rodents but more recently also zebrafish). However, it remains challenging to reproduce mechanical load stimuli and physical activity in laboratory experimental settings. Thus, more work to drive the innovation of advanced AC models is needed to recapitulate these subtle physiological influences. Here, we review the state-of-the-art in this field both in clinical and laboratory-based modeling scenarios. Specific attention will be focused on highlighting gaps in the knowledge and how they may be resolved by utilizing novel research methodology. Frontiers Media S.A. 2020-11-12 /pmc/articles/PMC7689294/ /pubmed/33281612 http://dx.doi.org/10.3389/fphys.2020.568535 Text en Copyright © 2020 Beffagna, Sommariva and Bellin. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Physiology
Beffagna, Giorgia
Sommariva, Elena
Bellin, Milena
Mechanotransduction and Adrenergic Stimulation in Arrhythmogenic Cardiomyopathy: An Overview of in vitro and in vivo Models
title Mechanotransduction and Adrenergic Stimulation in Arrhythmogenic Cardiomyopathy: An Overview of in vitro and in vivo Models
title_full Mechanotransduction and Adrenergic Stimulation in Arrhythmogenic Cardiomyopathy: An Overview of in vitro and in vivo Models
title_fullStr Mechanotransduction and Adrenergic Stimulation in Arrhythmogenic Cardiomyopathy: An Overview of in vitro and in vivo Models
title_full_unstemmed Mechanotransduction and Adrenergic Stimulation in Arrhythmogenic Cardiomyopathy: An Overview of in vitro and in vivo Models
title_short Mechanotransduction and Adrenergic Stimulation in Arrhythmogenic Cardiomyopathy: An Overview of in vitro and in vivo Models
title_sort mechanotransduction and adrenergic stimulation in arrhythmogenic cardiomyopathy: an overview of in vitro and in vivo models
topic Physiology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7689294/
https://www.ncbi.nlm.nih.gov/pubmed/33281612
http://dx.doi.org/10.3389/fphys.2020.568535
work_keys_str_mv AT beffagnagiorgia mechanotransductionandadrenergicstimulationinarrhythmogeniccardiomyopathyanoverviewofinvitroandinvivomodels
AT sommarivaelena mechanotransductionandadrenergicstimulationinarrhythmogeniccardiomyopathyanoverviewofinvitroandinvivomodels
AT bellinmilena mechanotransductionandadrenergicstimulationinarrhythmogeniccardiomyopathyanoverviewofinvitroandinvivomodels